News » Value-based Care in Myeloma - Novel Assay Identifies Carfilzomib-resistant...

Value-based Care in Myeloma - Novel Assay Identifies Carfilzomib-resistant Cells in Patients with Myeloma

Robert Hawley, Ph.D., chair of anatomy and cell biology, King Fahd Professor of Anatomy and Cell Biology, and professor of anatomy and regenerative biology, was featured in Value-based Care in Myeloma for his recent research published in the Journal of American Hematology that may help to identify patients with myeloma who will or will not respond to certain treatments.